Paroxysmal central nervous system disorders
Gene: PER2
Review and rating from James Polke (Neurogenetics Laboratory, Institute of Neurology, London) was collated (February 2019) on behalf of London North GLH for the GMS Neurology specialist test group.Created: 2 Sep 2019, 2:39 p.m. | Last Modified: 2 Sep 2019, 2:39 p.m.
Panel Version: 0.26
Review and rating from Tracy Lester (Oxford Medical Genetics Laboratories, Oxford University Hospitals NHS Foundation Trust) was collated (February 2019) on behalf of West Midlands, Oxford and Wessex GLH for the GMS Neurology specialist test group.Created: 2 Sep 2019, 1:39 p.m. | Last Modified: 2 Sep 2019, 1:39 p.m.
Panel Version: 0.23
Insufficient evidenceCreated: 2 Sep 2019, 1:30 p.m. | Last Modified: 2 Sep 2019, 1:30 p.m.
Panel Version: 0.22
Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
Phenotypes
Advanced sleep phase syndrome, familial, 1, 604348
Publications
Gene: per2 has been classified as Red List (Low Evidence).
Source NHS GMS was added to PER2.
Source London North GLH was added to PER2.
Source Wessex and West Midlands GLH was added to PER2.
Added phenotypes Advanced sleep phase syndrome, familial, 1, 604348 for gene: PER2
gene: PER2 was added gene: PER2 was added to Paroxysmal neurological disorders, pain disorders and sleep disorders. Sources: Expert Review Red Mode of inheritance for gene: PER2 was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted Publications for gene: PER2 were set to 11232563 Phenotypes for gene: PER2 were set to Advanced sleep phase syndrome, familial, 1, 604348